(Q40312488)

English

HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate

scientific article published on 9 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jorge Elias Kalil Filho

6

object named as

Jorge Kalil

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Milton T Guerino

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Edilberto Postol

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lea M F Demarchi

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Carlo O Martins

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Luiz R Mundel

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Luiza Guilherme

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

9 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

8250-8256

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The global burden of group A streptococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Autoimmune sequence of streptococcal M protein shared with the intermediate filament protein, vimentin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Sequence of myosin-crossreactive epitopes of streptococcal M protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Immunologic relationship of group A streptococcal strains and human heart tissue. Possible significance for the pathogenesis of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Pathogenesis of group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Progress in group A streptococcal vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Immunogenicity of a 26-valent group A streptococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Towards a vaccine against rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Anti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULES

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Mice lacking all conventional MHC class II genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

T cell mimicry in inflammatory heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Molecular evolution of the myosin family: relationships derived from comparisons of amino acid sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Molecular mechanics of mouse cardiac myosin isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

New insights into myosin evolution and classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.113

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.08.113

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40312488&oldid=1895000081"